Table 2 Characteristics of study population
No levothyroxine | Levothyroxine | p-value | |
|---|---|---|---|
N = 64 | N = 33 | ||
Mean and 95% CI for mean | |||
Number of other diseases | 2.4 (1.91–2.90) | 2.79 (2.32–3.25) | 0.32 |
Number of regularly taken medicines | 3.05 (2.15–3.95) | 3.45 (2.63–4.28) | 0.65 |
FIQ score (mean) | 44.42 (39.87–48.97) | 41.07 (34.36–47.77) | 0.36 |
PHQ-9 score | 10.05 (8.64–11.46) | 10.52 (8.39–12.64) | 0.71 |